high cholesterol and glp 1 Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? The Role of GLP-1RA Medications

Energy expenditure (EE) data were analyzed using the EE analysis of covariance (ANCOVA) analysis provided by the NIDDK Mouse Metabolic Phenotyping Centers (MMPC, www.mmpc.org) using their Energy Expenditure Analysis page ( and supported by grants DK076169 and DK115255

Theres a lot of research happening now to see how GLP-1 receptor agonists may impact a range of health conditions

The FDA has found fraudulent products (masquerading as the weight loss drugs) and has issued warning letters to stop the distribution of illegally marketed semaglutide

Nidorf SM, Fiolet ATL, Mosterd A et al (2020) Colchicine in patients with chronic coronary disease

both require a washout before conception planning

Vice President, Thought Leadership at IQVIA, head of Obesity Initiative, Visiting Faculty member, AVT Business School, Copenhagen What a great webinar yesterday on the development of the global market for prescription Obesity Medicines from now to 2030